Predictive oncology stock.

Predictive Oncology stock price prediction is an act of determining the future value of Predictive Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Predictive Oncology's future price could yield a significant profit.View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Predictive Oncology Inc. Company to host investor call and webcast today, May 15th, at 5:30pm EDT. EAGAN, Minn., May 15, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science ...The estimated Net Worth of J Melville Engle is at least $103 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $99,663 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Predictive Oncology Inc. Watch list After Hours Last Updated: Nov 13, 2023 7:52 p.m. EST Delayed quote $ 3.0500 -0.14 -4.39% After Hours Volume: 35 Advanced …

Nov 14, 2023 · Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ... Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

Admittedly, Gilead is starting from scratch in oncology, with only three approved products - for context, Bristol Myers Squibb markets and sells 9 major oncology products, which will likely drive ...Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, ...

Predictive Oncology Inc. Weekly Stock List Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The third-quarter earnings season is ... This article will tell you the best AI stocks under $1 to buy right now! ... Predictive Oncology is a Minnesota-based data and AI-driven discovery services company providing predictive models of tumor drug response. One of the subsidiaries of Predictive Oncology, TumorGenesis, utilizes specific and highly differentiated methods to grow …The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ...Nov 29, 2023 · The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period.

predictive oncology inc. certificate of designation of preferences, rights and limitations of. series e convertible preferred stock pursuant to section 151 of the. delaware general corporation law . effective june 13, 2019 .

Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.

Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Aug 10, 2023 · Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ... Apr 20, 2023 · Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ... The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...Predictive Oncology “is a data and AI-driven discovery services company that provides predictive models of tumor drug response.” One of Predictive Oncology’s subsidiaries, TumorGenesis ...Get a real-time Predictive Oncology Inc. (POAI) stock price quote with breaking news, financials, statistics, charts and more.

The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that ...The estimated Net Worth of J Melville Engle is at least $892 mil dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $888,827 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.predictive oncology inc. certificate of designation of preferences, rights and limitations of. series e convertible preferred stock pursuant to section 151 of the. delaware general corporation law . effective june 13, 2019 .The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...

Information on stock, financials, earnings, subsidiaries, investors, and executives for Predictive Oncology. Use the PitchBook Platform to explore the full ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

12 brokers have issued 12-month price objectives for Rain Oncology's stock. Their RAIN share price targets range from $11.00 to $24.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 1,431.5% from the stock's current price.12 brokers have issued 12-month price objectives for Rain Oncology's stock. Their RAIN share price targets range from $11.00 to $24.00. On average, they anticipate the company's stock price to reach $17.00 in the next year. This suggests a possible upside of 1,431.5% from the stock's current price.Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.

The estimated Net Worth of J Melville Engle is at least $60 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $56,950 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.

8 Wall Street research analysts have issued 1-year target prices for Kura Oncology's shares. Their KURA share price targets range from $10.50 to $37.00. On average, they predict the company's share price to reach $27.31 in the next twelve months. This suggests a possible upside of 185.7% from the stock's current price.

Predictive Oncology : If you can look past a reverse stock split, POAI stock is one worth watching. Rekor Systems ( REKR ): The company has a first-mover advantage in a sector that has the ...The estimated Net Worth of Richard L Gabriel is at least $7.57 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $5,234 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.We changed our name from Skyline Medical, Inc. to Precision Therapeutics, Inc. on February 1, 2018 and to Predictive Oncology Inc. on June 13, 2019. Our address is 2915 Commers Drive, Suite 900, Eagan, Minnesota 55121. Our telephone number is (651) 389-4800, and our website address is www.predictive-oncology.com.Benzinga — Why Predictive Oncology Stock Is Getting Hammered News • Apr 13, 2023 Digiday — ‘All options are on the table’: Why Version1 is seeking a merger with another esports companyTheir ZOM share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 3,421.1% from the stock's current price. View analysts price targets for ZOM or view top-rated stocks among Wall Street analysts.Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country. Predictive Oncology Inc. (POAI) Stock Price | Stock Quote Nasdaq - MarketScreener PREDICTIVE ONCOLOGY INC. Predictive Oncology Inc. Stock price …Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued. Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...This article will tell you the best AI stocks under $1 to buy right now! ... Predictive Oncology is a Minnesota-based data and AI-driven discovery services company providing predictive models of tumor drug response. One of the subsidiaries of Predictive Oncology, TumorGenesis, utilizes specific and highly differentiated methods to grow …

PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERSFor Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ...Instagram:https://instagram. options simulationcryptocurrency applicationsjinko solar holdinglennar homes stock Feb 24, 2021 · Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ... swan etfhdv stocks What this means: Predictive Oncology Inc (POAI) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives POAI a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. POAI rank of 10 means that it ranks below 90% of stocks.The first of these is Predictive Oncology (NASDAQ: POAI). The company uses a proprietary AI platform to identify drugs that are likely to work against specific tumors. To facilitate this, the ... nasdaq etf list The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the …Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.